Ophthalmology, Uveitis and Ocular Inflammatory Disease · Boston, MA
NPI
1053553867
Since 2009
Specialty
Ophthalmology, Uveitis and Ocular Inflammatory Disease
Code 207WX0108X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
50 Staniford St, Suite 600
Boston, MA, 02114
Phone (617) 367-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$239K
3,327 services
Medicare patients, 2024
581
Average age 74
Drug cost, 2024
$818K
2,073 prescriptions
Company payments, 2025
$6,589
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lana M Rifkin was code 99214 (office e&m - established), 944 times for 390 patients. In total Lana M Rifkin billed 3,327 services in 38 codes, and Medicare paid $239K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 944 | 390 | $97.86 | $92K |
| J3299 Injection, triamcinolone acetonide (xipere), 1 mg | Office | 684 | 11 | $38.05 | $26K |
| 92134 Computerized Ophthalmic Imaging | Office | 524 | 281 | $31.48 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 295 | 181 | $13.42 | $3,960 |
| 92014 Ophthalmological E&M | Office | 150 | 133 | $87.05 | $13K |
| 99215 Office E&M - Established | Office | 101 | 71 | $132.23 | $13K |
| 99213 Office E&M - Established | Office | 92 | 81 | $63.93 | $5,882 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 80 | 14 | $0.77 | $61.24 |
| 92250 Angiography | Office | 44 | 41 | $28.49 | $1,253 |
| 92235 Angiography | Office | 40 | 38 | $137.01 | $5,481 |
| 92083 Vision, Hearing, and Speech Services | Office | 29 | 29 | $49.01 | $1,421 |
| 99205 Office E&M - New | Office | 26 | 26 | $177.42 | $4,613 |
| 99204 Office E&M - New | Office | 23 | 23 | $135.03 | $3,106 |
| 92133 Computerized Ophthalmic Imaging | Office | 23 | 23 | $25.05 | $576 |
| 92012 Ophthalmological E&M | Office | 23 | 22 | $70.60 | $1,624 |
By year: 2022 $244K for 2,528 services; 2023 $203K for 2,901 services; 2024 $239K for 3,327 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lana M Rifkin prescribed most often to Medicare patients was Prednisolone Acetate, with 460 prescriptions and refills. In total Lana M Rifkin wrote 2,073 Medicare prescriptions that cost $818K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 460 | 807 | 206 | $23K |
| Difluprednate Generic | 318 | 392 | 122 | $32K |
| Valacyclovir Valacyclovir Hcl | 260 | 514 | 85 | $15K |
| Prednisone Generic | 120 | 143 | 32 | $683 |
| Timolol Maleate Generic | 115 | 224 | 35 | $917 |
| Mycophenolate Mofetil Generic | 110 | 183 | 22 | $18K |
| Humira(Cf) Pen Adalimumab | 77 | 80 | 11 | $578K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 77 | 150 | 30 | $1,563 |
| Brimonidine Tartrate Generic | 71 | 164 | 28 | $862 |
| Methotrexate Methotrexate Sodium | 60 | 114 | 17 | $1,087 |
| Latanoprost Generic | 59 | 79 | Under 11 | $342 |
| Leucovorin Calcium Generic | 51 | 95 | 13 | $800 |
| Dorzolamide Hcl Generic | 44 | 92 | 20 | $643 |
| Simbrinza Brinzolamide/Brimonidine Tart | 19 | 25 | Under 11 | $4,300 |
| Fluorometholone Generic | 19 | 39 | Under 11 | $1,228 |
Brand drugs: - claims; generic drugs: 1,203 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lana M Rifkin $6,589 ($6,589 in general payments such as food, travel and fees) from 8 companies. The largest payer was Bausch & Lomb Americas Inc. with $6,019.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 2 | $6,019 |
| Dompe US, Inc. | 2 | $168 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $118 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $101 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $77.87 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $40.05 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $36.41 |
| Abbvie Inc. ABBV | 1 | $28.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.